IRIS UniCatt

Macchia, Gabriella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.831
EU - Europa 8.234
AS - Asia 7.610
SA - Sud America 1.364
Continente sconosciuto - Info sul continente non disponibili 814
AF - Africa 238
OC - Oceania 15
Totale 31.106
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.390
SG - Singapore 3.490
DE - Germania 2.964
CN - Cina 1.708
SE - Svezia 1.368
BR - Brasile 1.093
IT - Italia 930
VN - Vietnam 728
FR - Francia 660
UA - Ucraina 568
GB - Regno Unito 397
IN - India 370
IE - Irlanda 327
FI - Finlandia 271
CA - Canada 245
ID - Indonesia 221
JP - Giappone 203
PL - Polonia 193
BD - Bangladesh 155
HK - Hong Kong 155
TR - Turchia 139
RU - Federazione Russa 131
AR - Argentina 85
NL - Olanda 82
IQ - Iraq 75
MX - Messico 74
BE - Belgio 56
CI - Costa d'Avorio 54
ZA - Sudafrica 51
CO - Colombia 47
CZ - Repubblica Ceca 44
EC - Ecuador 44
AT - Austria 43
ES - Italia 43
SA - Arabia Saudita 42
IR - Iran 33
JM - Giamaica 32
VE - Venezuela 31
KR - Corea 30
LT - Lituania 30
PK - Pakistan 30
EG - Egitto 27
MA - Marocco 27
PH - Filippine 27
KE - Kenya 26
UZ - Uzbekistan 23
AE - Emirati Arabi Uniti 22
CL - Cile 20
JO - Giordania 20
CR - Costa Rica 18
MY - Malesia 18
NP - Nepal 15
TN - Tunisia 15
PY - Paraguay 14
CH - Svizzera 13
IL - Israele 13
RO - Romania 13
UY - Uruguay 12
EU - Europa 11
AL - Albania 10
AU - Australia 10
TT - Trinidad e Tobago 10
AZ - Azerbaigian 9
BH - Bahrain 9
DZ - Algeria 9
GR - Grecia 9
HU - Ungheria 9
PE - Perù 9
RS - Serbia 9
BG - Bulgaria 8
GT - Guatemala 8
KG - Kirghizistan 8
NI - Nicaragua 8
OM - Oman 8
PT - Portogallo 8
SN - Senegal 8
SV - El Salvador 8
BO - Bolivia 7
DK - Danimarca 7
DO - Repubblica Dominicana 7
PS - Palestinian Territory 7
SY - Repubblica araba siriana 7
AM - Armenia 6
EE - Estonia 6
ET - Etiopia 6
HN - Honduras 6
LK - Sri Lanka 6
MT - Malta 6
KZ - Kazakistan 5
LB - Libano 5
LU - Lussemburgo 5
NZ - Nuova Zelanda 5
PA - Panama 5
SI - Slovenia 4
SK - Slovacchia (Repubblica Slovacca) 4
TW - Taiwan 4
BB - Barbados 3
BS - Bahamas 3
HR - Croazia 3
LA - Repubblica Popolare Democratica del Laos 3
Totale 30.243
Salva come PNG Salva come JPEG
Città #
Singapore 1.921
Chandler 1.365
Ashburn 1.287
San Jose 1.215
Beijing 379
Jacksonville 335
Dublin 324
Los Angeles 299
Council Bluffs 270
The Dalles 267
New York 260
San Mateo 260
Ho Chi Minh City 246
Lauterbourg 216
Nanjing 201
Milan 196
Jakarta 194
Wilmington 185
Hanoi 179
Warsaw 169
Tokyo 167
Dearborn 165
Dallas 161
Munich 159
Boston 144
Rome 142
Nürnberg 140
Hefei 132
Hong Kong 132
Frankfurt am Main 131
Bremen 123
Woodbridge 116
Marseille 112
Helsinki 109
São Paulo 108
Hyderabad 107
Ann Arbor 106
Houston 95
Izmir 88
Lawrence 87
Santa Clara 87
Cattolica 84
Princeton 79
Moscow 78
Fairfield 76
Nanchang 76
Chicago 69
Atlanta 67
Seattle 66
St Louis 66
Buffalo 63
Redwood City 57
Brussels 55
Toronto 55
Abidjan 54
Orem 54
Phoenix 52
Brooklyn 47
London 45
Shanghai 45
Montreal 44
Boardman 43
Leawood 40
Zhengzhou 37
Augusta 36
Düsseldorf 36
Guangzhou 36
Stockholm 36
University Park 36
Da Nang 35
Turku 35
Kent 34
Paris 34
Shenyang 34
Amsterdam 32
Hebei 32
Kunming 32
Phoenixville 32
Tianjin 31
Denver 30
Changsha 29
Fremont 29
Johannesburg 29
Lancaster 29
Nuremberg 29
Detroit 28
Lappeenranta 28
Cambridge 27
Pune 27
Rio de Janeiro 27
Jiaxing 26
Seoul 26
Falls Church 25
Mountain View 25
Mumbai 25
Norwalk 25
Baghdad 24
Haiphong 24
Mexico City 24
Nairobi 24
Totale 14.802
Salva come PNG Salva come JPEG
Nome #
Clinical outcome of recurrent locally advanced cervical cancer (lacc) submitted to primary multimodality therapies 872
Multidisciplinary Tumor Board Smart Virtual Assistant in Locally Advanced Cervical Cancer: A Proof of Concept 317
Results of a phase II study of Short-course Accelerated Radiation Therapy (SHARON) for multiple brain metastases 306
Machine-learning prediction of treatment response to stereotactic body radiation therapy in oligometastatic gynecological cancer: A multi-institutional study 298
Short-Course Accelerated Radiotherapy in Palliative Treatment of Advanced Pelvic Malignancies: A Phase I Study 243
Long-term analysis of clinical outcome and complications in locally advanced cervical cancer patients administered concomitant chemoradiation followed by radical surgery 239
Mammography before post-operative radiotherapy in conservatively managed breast cancer patients: is it useful? 238
Applicator-guided volumetric-modulated arc therapy for low-risk endometrial cancer 229
Radioprotective effect of moderate wine consumption in patients with breast carcinoma. 228
Multiple tumor marker elevation in androgen ablation-refractory prostate cancer with long-term response to metronomic chemotherapy: a case report 223
Volumetric modulated arc therapy with simultaneous integrated boost for locally advanced rectal cancer 218
Stereotactic Ablative Radiation Therapy for Oligometastatic Ovarian Cancer Lymph Node Disease: The MITO-RT3/RAD Phase II Trial 214
Planning comparison between standard and conformal 3D techniques in post-operative radiotherapy of gastric cancer: a systematic review 211
A systematic review of resectability and survival after concurrent chemoradiation in primarily unresectable pancreatic cancer. 209
Chemoradiation and brachytherapy in biliary tract carcinoma - Long-term results 209
Evaluation of early regression index as response predictor in cervical cancer: A retrospective study on T2 and DWI MR images 208
Development of an Enomogram to Predict the Rate of Loco-Regional Control After Radio-Chemotherapy and Interventional Radiotherapy in Cervical Cancer 207
Stereotactic body radiotherapy and poly (ADP-ribose) polymerase inhibitors in ovarian cancer: a knowledge and attitudes survey in collaboration with the Italian Association of Radiation Oncology (AIRO) and Multicenter Italian Trials in Ovarian Cancer (MITO) groups 205
Intensity-modulated radiotherapy with simultaneous integrated boost to dominant intraprostatic lesion: preliminary report on toxicity 204
Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost in Patients With Brain Oligometastases: A Phase 1 Study (ISIDE-BM-1) 204
Endocavitary in vivo dosimetry for IMRT treatments of gynecologic tumors 203
Can radicality of surgery be safely modulated on the basis of MRI and PET/CT imaging in locally advanced cervical cancer patients administered preoperative treatment? 201
Phase I-II studies on accelerated IMRT in breast carcinoma: technical comparison and acute toxicity in 332 patients. 201
Intraluminal brachytherapy without stenting in intrahepatic papillary cholangiocarcinoma: a case report 198
In Vivo Portal Dosimetry by an Ionization Chamber 198
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 198
Clinical target volume delineation including elective nodal irradiation in preoperative and definitive radiotherapy of pancreatic cancer 196
Chemoradiation and brachytherapy in extrahepatic bile duct carcinoma 196
Concomitant boost radiotherapy and multidrug chemotherapy in the neoadjuvant treatment of locally advanced rectal cancer: results of a phase II study 195
A complete pathological response to treatment in a young patient with locally advanced minimal deviation adenocarcinoma of the uterine cervix undergoing chemoradiation followed by radical surgery 194
Quality of life and toxicity of stereotactic radiotherapy in pancreatic tumors: a case series 192
Long-term Analysis of Gemcitabine-based Chemoradiation after Surgical Resection for Pancreatic Adenocarcinoma 192
Capecitabine based postoperative accelerated chemoradiation of pancreatic carcinoma. A dose-escalation study. 191
Early radiation-induced mucosal changes evaluated by proctoscopy: Predictive role of dosimetric parameters 187
Volumetric intensity modulated arc therapy for stereotactic body radiosurgery in oligometastatic breast and gynecological cancers: feasibility and clinical results 185
3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I-II study (ADA-RT-1) 184
Postoperative intensity modulated radiation therapy in high risk prostate cancer: A dosimetric comparison. 183
Intraoperative radiation therapy in resected pancreatic carcinoma: long-term analysis. 183
Applicator-guided volumetric-modulated arc therapy for low-risk endometrial cancer 183
Chronic rhinosinusitis with nasal polyps impact in severe asthma patients: Evidences from the Severe Asthma Network Italy (SANI) registry 183
Advanced head and neck cancer in older adults: Results of a short course accelerated radiotherapy trial 183
Accelerated intensity-modulated radiotherapy plus temozolomide in patients with glioblastoma: a phase I dose-escalation study (ISIDE-BT-1) 182
Long-term analysis of gemcitabine-based chemoradiation after surgical resection for pancreatic adenocarcinoma 181
A phase I study of short-course accelerated whole brain radiation therapy for multiple brain metastases 181
Preoperative Chemoradiation With VMAT-SIB in Rectal Cancer: A Phase II Study 180
Extracranial radiosurgery with volumetric modulated arc therapy: Feasibility evaluation of a phase I trial 179
Stereotactic radiosurgery (SRS) with volumetric modulated arc therapy (VMAT): interim results of a multi-arm phase I trial (DESTROY-2) 179
Can radicality of surgery be safely modulated on the basis of MRI and PET/CT imaging in locally advanced cervical cancer patients administered preoperative treatment? 175
Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase ii study (ester-1). 174
Early proctoscopy is a surrogate endpoint of late rectal toxicity in prostate cancer treated with radiotherapy 174
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 173
Forward planned intensity modulated radiotherapy (IMRT) for whole breast postoperative radiotherapy. Is it useful? When? 172
Inter-observer variability of clinical target volume delineation in radiotherapy treatment of pancreatic cancer: a multi-institutional contouring experience 172
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 170
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: preliminary results of a phase II trial 170
FOLFIRI-bevacizumab and concurrent low-dose radiotherapy in metastatic colorectal cancer: preliminary results of a phase I-II study 170
Patterns of radiotherapy practice for pancreatic cancer: Results of the Gastrointestinal Radiation Oncology Study Group multi-institutional survey 170
Management of oligometastatic ovarian cancer recurrence during PARP inhibitor maintenance 168
Adjuvant volumetric-modulated arc therapy with simultaneous integrated boost in endometrial cancer. Planning and toxicity comparison 168
Incidence and management of noncancer pain in cancer patients referred to a radiotherapy center 168
Initial clinical experience with Epid-based in-vivo dosimetry for VMAT treatments of head-and-neck tumors 166
An in-vivo dosimetry procedure for Elekta step and shoot IMRT 164
A Large, Multicenter, Retrospective Study on Efficacy and Safety Of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups 164
Radiochemotherapy with Gemcitabine in Unresectable Extrahepatic Cholangiocarcinoma: Long-term Results of a Phase II Study 164
Eccrine Syringofibroadenoma radiation treatment of an unusual presentation 163
Radiotherapy and concurrent metronomic chemotherapy in hormone-refractory prostate carcinoma: a Phase I study 163
Short-course radiotherapy in elderly patients with early stage non-melanoma skin cancer: a phase II study 163
A phase I dose-escalation study (iside-bt-1) of accelerated imrt with temozolomide in patients with glioblastoma. 162
Forward-planned intensity modulated radiation therapy using a cobalt source: A dosimetric study in breast cancer 162
Radioprotective effect of calcium channel blockers against late rectal bleeding in prostate cancer 162
Adequacy of Pain Management in Patients Referred for Radiation Therapy: A Subanalysis of the Multicenter ARISE-1 Study 161
Real time transit dosimetry for the breath-hold radiotherapy technique experience 160
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 160
3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I-II study (ADA-RT-1) 159
CT angiography-based radiomics as a tool for carotid plaque characterization: a pilot study 157
Further Clarification of Pain Management Complexity in Radiotherapy: Insights from Modern Statistical Approaches 157
Assessing the feasibility of volumetric-modulated arc therapy using simultaneous integrated boost (SIB-VMAT): An analysis for complex head-neck, high-risk prostate and rectal cancer cases 157
Feasibility Study Of Moderately Accelerated Intensity-Modulated Radiotherapy Plus Concurrent Weekly Cisplatin After Induction Chemotherapy In Locally Advanced Head-And Neck Cancer. 156
Neoadjuvant Accelerated Concomitant Boost Radiotherapy and Multidrug Chemotherapy in Locally Advanced Rectal Cancer: A Dose-Escalation Study 155
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 154
Simultaneous Integrated Boost Volumetric Modulated Arc Therapy in the Postoperative Treatment of High-Risk to Intermediate-Risk Endometrial Cancer: Results of ADA II Phase 1-2 Trial 151
Radiomics-based prediction of two-year clinical outcome in locally advanced cervical cancer patients undergoing neoadjuvant chemoradiotherapy 151
Concomitant boost plus large-field preoperative chemoradiation in locally advanced uterine cervix carcinoma: Phase II clinical trial final results (LARA-CC-1) 150
Human papillomavirus independent status on pathologic response and outcomes in locally advanced cervical cancer managed with chemoradiotherapy followed by surgery 149
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 149
Successful Treatment of a Young Patient with Locally Advanced Clear Cell Adenocarcinoma of the Uterine Cervix Undergoing Chemoradiation Followed by Radical Surgery 149
18 F-FDG Pet-Guided External Beam Radiotherapy in Iodine-Refractory Differentiated Thyroid Cancer: A Pilot Study 149
Palliative short-course radiation therapy in rectal cancer: A phase 2 study 148
Predictive Factors of Late-onset Rectal Mucosal Changes After Radiotherapy of Prostate Cancer 147
Concomitant boost dose escalation plus large-field preoperative chemoradiation in locally advanced carcinoma of the uterine cervix: results of a phase I study (LARA-CC-1). 146
Concurrent Chemoradiation with Concomitant Boost in Locally Advanced Rectal Cancer: A Phase II Study 146
Cervical cancer patterns of care in Italy: A radiation oncology survey of MITO and AIRO GYN groups 146
Role of comorbidities in locally advanced cervical cancer patients administered preoperative chemoradiation: Impact on outcome and treatment-related complications. 145
Stereotactic radiotherapy in recurrent gynecological cancer: a case series 145
Palliative two-dimensional radiotherapy of pancreatic carcinoma: a feasibility study. 145
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: Preliminary results of a phase II trial 144
Neo-adjuvant platinum-based chemotherapy followed by chemoradiation and radical surgery in locally advanced cervical cancer (Lacc) patients: A phase II study 144
Correction to: Hypofractionated sequential radiotherapy boost: a promising strategy in inoperable locally advanced pancreatic cancer patients (Journal of Cancer Research and Clinical Oncology, (2021), 147, 3, (661-667), 10.1007/s00432-020-03411-7) 144
Efficacy of stereotactic body radiotherapy and response prediction using artificial intelligence in oligometastatic gynaecologic cancer 143
Linac-based extracranial radiosurgery with Elekta volumetric modulated arc therapy and an anatomy-based treatment planning system: Feasibility and initial experience 142
Totale 18.756
Salva come PNG Salva come JPEG
Categoria #
all - tutte 120.022
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 120.022
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.305 0 0 0 107 111 57 23 216 62 111 308 310
2022/20233.828 521 539 262 610 263 423 223 292 419 79 148 49
2023/20241.701 66 484 75 129 52 215 101 131 20 52 237 139
2024/20253.772 106 84 240 136 419 103 97 175 600 446 729 637
2025/202610.097 1.417 296 552 962 1.702 580 1.715 619 766 775 387 326
2026/20273.506 507 1.380 688 931 0 0 0 0 0 0 0 0
Totale 31.106